Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GHRS
#7030
GH Research PLC Ordinary Shares
14.850
0
-3.51%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.51%
Variazione Mensile
-9.12%
Variazione di 6 mesi
+4.87%
Variazione Annuale
+4.87%
Chiusura Precedente
15.390
0
Open
14.850
0
Bid
Ask
Low
14.850
0
High
14.850
0
Volume
22
Mercati
Mercato Azionario Statunitense
Salute
GHRS
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
52.03 M
208.1 M
Valuation ratios
Enterprise value
364.2 M
2.36 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Notizie
RBC Capital повысил целевую цену акций GH Research до $40
GH Research stock price target raised to $40 from $33 at RBC Capital
Eli Lilly and Regencell among market cap stock movers on Wednesday
Целевая цена акций GH Research повышена до $29 с $19 в Needham
GH Research stock price target raised to $29 from $19 at Needham
Акции GH Research растут после повышения целевой цены Canaccord
GH Research stock jumps as Canaccord raises price target on FDA hold lift
Акции GH Research растут после снятия FDA клинического запрета
GH Research stock rises as FDA lifts clinical hold on GH001
Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug
Tesla, Chevron among market cap stock movers on Monday
TD Cowen подтверждает рейтинг "Покупать" для акций GH Research